Journal of Vaccine Research 2024, Vol.14, No.5, 269-277 http://medscipublisher.com/index.php/jvr 277 M., Kalina W., Kyratsous C.A., Cooper D., Dormitzer P.R., Jansen K.U., and Türeci Ö., 2020, COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses, Nature, 586(7830): 594-599. https://doi.org/10.1038/s41586-020-2814-7 PMID: 32998157 Shin M.D., Shukla, S., Chung Y.H., Beiss V., Chan S.K., Ortega-Rivera O.A., and Steinmetz N.F., 2021, COVID-19 vaccine development and a potential nanomaterial path forward, Nature Nanotechnology, 15(8): 646-655. https://doi.org/10.1038/s41565-020-0737-y PMID: 32669664 Siewert C.D., Haas H., and Cornelis J.J., 2020, PLGA-based nanoparticles for mRNA delivery: past, present, and future, Journal of Controlled Release, 328: 759-774. https://doi.org/10.1016/j.jconrel.2020.09.046 Tanne J.H., 2020, Covid-19: FDA approves Pfizer-BioNTech vaccine within days of application, BMJ, 371: m4707. https://doi.org/10.1136/bmj.m4707 Thompson M.G., Burgess J.L., Naleway A.L., Tyner H., Yoon S.K., Meece J., Olsho L.E.W., Caban-Martinez A.J., Fowlkes A.L., Lutrick K., Groom H.C., Dunnigan K., Odean M.J., Hegmann K., Stefanski E., Edwards L.J., Schaefer-Solle N., Grant L., Ellingson K., Kuntz J.L, Zunie T., Thiese M.S., Ivacic L., Wesley M.G., Lamberte J.M., Sun X.X, Smith M.E., Phillips A.L., Groover K.D., Yoo Y.M., Gerald J., Brown R.T., Herring M.K., Joseph G., Beitel S., Morrill T.C., Mak J., Rivers P., Poe B.P., Lynch B., Zhou Y.T., Zhang J., Kelleher A., Li Y., Dickerson M., Hanson E., Guenther K., Tong S.X., Bateman A., Reisdorf E., Barnes J., Azziz-Baumgartner E., Hunt D.R., Arvay M.L., Kutty P., Fry A.M., and Gaglani M., 2021, Prevention and attenuation of COVID-19 with the BNT162b2 and mRNA-1273 vaccines, The New England Journal of Medicine, 385(4): 320-329. https://doi.org/10.1056/NEJMoa2107058 Walsh E.E., Frenck R.W., Falsey A.R., Kitchin N., Absalon J., Gurtman A., Lockhart S., Neuzil K., Mulligan M.J., Bailey R., Swanson K.A., Ping Li P., Koury K., Kalina W., Cooper D., Fontes-Garfias C., Shi P.Y., Türeci Ö., Tompkins K.R., Lyke K.E., Raabe V., Dormitzer P.R., Jansen K.U., Şahin U., and Gruber W.C., 2020, Safety and immunogenicity of two RNA-based COVID-19 vaccine candidates, The New England Journal of Medicine, 383(25): 2439-2450. https://doi.org/10.1056/NEJMoa2027906 PMID: 33053279 PMCID: PMC7583697 Wang W., 2024, Studying the dynamic changes of the immune system through single-cell omics, International Journal of Molecular Medical Science, 14(1): 29-41. https://doi.org/10.5376/ijmms.2024.14.0005 Wouters O.J., Shadlen K.C., Salcher-Konrad M., Pollard A.J., Larson H.J., Teerawattananon Y., and Jit M., 2021, Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment, The Lancet, 397(10278): 1023-1034. https://doi.org/10.1016/S0140-6736(21)00306-8 PMID: 33587887 PMCID: PMC7906643
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==